Skip to main content

Table 2 Multivariable Cox regression for breast cancer-specific mortality and overall mortality associated with different hormone receptor statuses (only statistically significant results are shown in bold)

From: Survival trends of patients with metaplastic breast carcinoma with different hormone receptor statuses: a SEER-based retrospective cohort study

 

Hormone Receptor-Negative

Hormone Receptor-Positive

 

Overall Survival

Breast Cancer-Specific Survival

Overall Survival

Breast Cancer-Specific Survival

Variablea

Adjusted HRs (95% CI)

P

Adjusted HRs (95% CI)

P

Adjusted HRs

(95% CI)

P

Adjusted HRs

(95% CI)

P

Time Period

        

2000–2009

1

Ref

1

Ref

1

Ref

1

Ref

2010–2019

0.83 (0.71–0.97)

0.021

0.83 (0.69–1.00)

0.045

0.9 (0.66–1.24)

0.525

0.87 (0.61–1.24)

0.428

Age

        

< 50

1

Ref

1

Ref

1

Ref

1

Ref

≥ 50

1.50 (1.21–1.88)

< 0.001

1.33 (1.06–1.68)

0.016

1.60 (1.05–2.42)

0.027

1.52 (0.97–2.37)

0.066

Race/Ethnicity

        

Black

1

Ref

1

Ref

1

Ref

1

Ref

White

0.80 (0.65–1.00)

0.049

0.76 (0.59–0.97)

0.027

0.74 (0.50–1.10)

0.136

0.68 (0.44–1.06)

0.086

Hispanic

0.80 (0.58–1.08)

0.149

0.73 (0.52–1.03)

0.073

0.74 (0.41–1.32)

0.309

0.74 (0.39–1.39)

0.352

Other

0.76 (0.52–1.12)

0.173

0.70 (0.45–1.09)

0.113

0.53 (0.28–1.04)

0.063

0.56 (0.27–1.14)

0.111

T Stage

        

T0&T1

1

Ref

1

Ref

1

Ref

1

Ref

T2

1.57 (1.20–2.06)

0.001

1.65 (1.18–2.31)

0.003

2.47 (1.51–4.02)

< 0.001

3.21 (1.70–6.06)

< 0.001

T3

3.94 (2.94–5.28)

< 0.001

4.83 (3.37–6.90)

< 0.001

3.91 (2.22–6.87)

< 0.001

5.22 (2.58–10.59)

< 0.001

T4

5.51 (3.94–7.70)

< 0.001

7.08 (4.78–10.49)

< 0.001

7.04 (3.92–12.63)

< 0.001

9.72 (4.69–20.14)

< 0.001

Node Status

        

Negative

1

Ref

1

Ref

1

Ref

1

Ref

Positive

2.00 (1.66–2.41)

< 0.001

2.23 (1.82–2.74)

< 0.001

2.22 (1.57–3.13)

< 0.001

2.27 (1.56–3.32)

< 0.001

Unknown

2.07 (1.59–2.68)

< 0.001

1.76 (1.25–2.48)

0.001

2.57 (1.63–4.05)

< 0.001

1.70 (0.95–3.06)

0.076

Surgery Type

        

BCS

1

Ref

1

Ref

1

Ref

1

Ref

Mastectomy

1.39 (1.13–1.71)

0.002

1.32 (1.04–1.68)

0.024

1.31 (0.88–1.94)

0.180

1.27 (0.80–2.00)

0.311

Radiotherapy

        

No/Unknown

1

Ref

1

Ref

1

Ref

1

Ref

Yes

0.72 (0.60–0.86)

< 0.001

0.70 (0.58–0.86

0.001

0.70 (0.48–1.02)

0.062

0.67 (0.44–1.02)

0.059

Chemotherapy

        

No/Unknown

1

Ref

1

Ref

1

Ref

1

Ref

Yes

0.63 (0.52–0.75)

< 0.001

NAb

NA

0.55 (0.38–0.79)

0.001

0.70 (0.46–1.06)

0.093

  1. The analysis was adjusted for age, race, marital status, median household income, pathologic grade, T stage, lymph node status, surgery type, and receipt of radiation and chemotherapy
  2. Abbreviations: BCS, breast-conserving surgery; HR, hazard ratio; CI, confidence interval
  3. a Univariate regression analysis p = 0.468, which was not included in the multivariable Cox regression